Ankylosing spondylitis
We specifically reduce inflammatory activity in the spine, preventing stiffness and ossification of the joints.
About the disease
Ankylosing spondylitis (Bekhterev's disease) is chronic inflammation of the spine's joints. It usually begins at a young age and gradually leads to stiffness and, without control, to fusion of the vertebrae and loss of mobility. The key task is to hold back inflammation and preserve the back's flexibility.
We use a modified T-cell vaccination technology. It targets the immune cells that sustain inflammation and works selectively, without suppressing overall immunity.
This approach matters because standard treatment often relies on constant anti-inflammatory drugs and biologic therapy that lowers the body's overall defense. Immunotherapy helps control disease activity by a different route.
The method is used to reduce inflammatory activity and prevent stiffness. It is built into the overall plan together with therapeutic exercise and disease-modifying therapy.
The physician selects the regimen after assessing disease activity, the stage of changes in the spine and joints, drug tolerance, and records. The program is built individually.
Inflammation control
The method reduces inflammatory activity in the spine and joints.
Preserving mobility
Helps prevent stiffness and fusion of the vertebrae.
Selective action
Works precisely, without suppressing overall immunity.
A different route of control
A complement to anti-inflammatory and biologic therapy.
Part of the overall plan
Combines with therapeutic exercise and disease-modifying treatment.
T-cell vaccination
The method aims to stimulate immune reactions selectively directed at inactivating pathogenic autoimmune T-lymphocytes.
Collection and isolation
Autoaggressive T-lymphocytes — cells attacking the body's own tissues — are isolated from your blood.
Vaccine preparation
The isolated cells are processed and used to create a personalized T-cell vaccine.
Vaccination
Administering the vaccine triggers a regulatory immune response that selectively suppresses only the pathogenic cell clones.
Monitoring and support
Inflammatory activity decreases without suppressing general immunity; the course is adjusted based on dynamics.
Frequently asked questions
How does immunotherapy help in ankylosing spondylitis?
The method reduces inflammatory activity in the spine's joints and helps preserve mobility. It acts on the immune cells that sustain chronic inflammation.
Does the method affect overall immunity?
No. T-cell vaccination acts selectively on the pathogenic cells and does not suppress the body's whole defense, unlike some biologic drugs.
Will the method help preserve the back's flexibility?
That is its aim. By reducing inflammation, the method helps prevent stiffness and fusion of the vertebrae, especially if started in time.
Can the method be combined with usual treatment?
Yes. Immunotherapy is built into the overall plan together with therapeutic exercise and disease-modifying therapy; it complements them.
How does the treatment go?
After a consultation and assessment of disease activity, the physician builds an individual program. The method is gently tolerated and does not require constant immune suppression.
Can I come for treatment from another region?
Yes. The clinic is near Moscow (Khimki, Skhodnya) and accepts patients from other regions. The first consultation can be held remotely from your records.
Other directions
Multiple sclerosis
Selective inactivation of aggressive lymphocytes to protect the myelin sheath of nerve fibers.
Rheumatoid arthritis
Relief of joint inflammation and restoration of mobility without suppressing general immunity.
Autoimmune vasculitis
Relieving inflammation of the vascular wall to restore normal blood circulation.
Discuss your situation
Leave your contact details. Our medical coordinator will contact you shortly to answer any questions.